<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Pzena International Small Cap Value Fund Investor Class — News on 6ix</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class</link>
<description>Latest news and press releases for Pzena International Small Cap Value Fund Investor Class on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/pzena-international-small-cap-value-fund-investor-class" rel="self" type="application/rss+xml" />
<item>
<title>Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/spruce-biosciences-announces-pricing-of-public-offering-of-common-stock-and-pre-funded-warrants-6</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/spruce-biosciences-announces-pricing-of-public-offering-of-common-stock-and-pre-funded-warrants-6</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (“Spruce Biosciences”) (Nasdaq: SPRB), a late-stage biopharmaceutical company focused</description>
</item>
<item>
<title>Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/atrium-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-10</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/atrium-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-10</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO, April 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on April 20,</description>
</item>
<item>
<title>Onto Innovation Announces Strategic Partnership With Leading X-Ray Provider Rigaku To Advance Next-Generation Process Control Solutions</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-37</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-37</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>Systems delivered for advanced V-NAND and DRAM metrology, with expanding engagement across top-tier logic and memory customers WILMINGTON, Mass.--(BUSINESS</description>
</item>
<item>
<title>LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/lir-life-sciences-corp-announces-agreement-with-resilience-biosciences-inc-8</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/lir-life-sciences-corp-announces-agreement-with-resilience-biosciences-inc-8</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / April 20, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company")</description>
</item>
<item>
<title>MSA Safety Schedules First Quarter 2026 Earnings Conference Call</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/msa-safety-schedules-first-quarter-2026-earnings-conference-call-5</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/msa-safety-schedules-first-quarter-2026-earnings-conference-call-5</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>PITTSBURGH, April 20, 2026 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions</description>
</item>
<item>
<title>Flexsteel Industries, Inc. Reports Fiscal Third Quarter 2026 Results</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/flexsteel-industries-inc-reports-fiscal-third-quarter-2026-results-5</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/flexsteel-industries-inc-reports-fiscal-third-quarter-2026-results-5</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>DUBUQUE, Iowa--(BUSINESS WIRE)-- Flexsteel Industries, Inc. (NASDAQ: FLXS) (“Flexsteel” or the “Company”), one of the largest manufacturers, importers, and</description>
</item>
<item>
<title>Anne P. Noonan Elected to Celanese Board of Directors</title>
<link>https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/anne-p-noonan-elected-to-celanese-board-of-directors-5</link>
<guid isPermaLink="true">https://6ix.com/company/pzena-international-small-cap-value-fund-investor-class/news/anne-p-noonan-elected-to-celanese-board-of-directors-5</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Anne P. Noonan has been</description>
</item>
</channel>
</rss>